Salem Investment Counselors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-33
| Closed | -$1K | – | 525 |
|
|
2017
Q4 | $1K | Hold |
33
| – | – | ﹤0.01% | 535 |
|
|
2017
Q3 | $1K | Sell |
33
-37
| -53% | -$1.12K | ﹤0.01% | 537 |
|
|
2017
Q2 | $3K | Buy |
+70
| New | +$3K | ﹤0.01% | 545 |
|
|
2017
Q1 | – | Sell |
-70
| Closed | -$4K | – | 559 |
|
|
2016
Q4 | $4K | Hold |
70
| – | – | ﹤0.01% | 550 |
|
|
2016
Q3 | $42 | Sell |
70
-1,563
| -96% | -$938 | ﹤0.01% | 453 |
|
|
2016
Q2 | $108K | Sell |
1,633
-34
| -2% | -$2.25K | 0.01% | 247 |
|
|
2016
Q1 | $95K | Buy |
1,667
+34
| +2% | +$1.94K | 0.01% | 245 |
|
|
2015
Q4 | $384K | Buy |
1,633
+184
| +13% | +$43.3K | 0.05% | 191 |
|
|
2015
Q3 | $227K | Sell |
1,449
-20
| -1% | -$3.13K | 0.03% | 241 |
|
|
2015
Q2 | $556K | Sell |
1,469
-80
| -5% | -$30.3K | 0.07% | 178 |
|
|
2015
Q1 | $648K | Hold |
1,549
| – | – | 0.08% | 176 |
|
|
2014
Q4 | $424K | Sell |
1,549
-714
| -32% | -$195K | 0.05% | 200 |
|
|
2014
Q3 | $440K | Sell |
2,263
-123
| -5% | -$23.9K | 0.05% | 200 |
|
|
2014
Q2 | $584K | Sell |
2,386
-423
| -15% | -$104K | 0.07% | 180 |
|
|
2014
Q1 | $745K | Sell |
2,809
-152
| -5% | -$40.3K | 0.09% | 162 |
|
|
2013
Q4 | $1.08M | Hold |
2,961
| – | – | 0.14% | 136 |
|
|
2013
Q3 | $1.57M | Hold |
2,961
| – | – | 0.22% | 103 |
|
|
2013
Q2 | $693K | Buy |
+2,961
| New | +$693K | 0.1% | 157 |
|